Vijaya Diagnostic Centre Limited — Investor Meet, 07-11-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Vijaya Diagnostic reported Q2 FY26 consolidated revenue of Rs. 202 Cr (+10.2% YoY) and H1 revenue of Rs. 390 Cr (+15% YoY). Q2 EBITDA margin stood strong at 40.6%, with H1 at 40%, surpassing FY26 guidance. Q2 growth was softer due to lower monsoon-related diseases and early festive season, but Q3 started with increased footfalls. Bangalore hubs broke even faster than expected, driving confidence for further expansion including a new flagship centre. New hubs launched in Kolkata, AP, and Telangana. Pune is showing an uptick. Management targets 15% revenue CAGR, focusing on volume-driven growth. The company holds a robust cash balance of Rs. 295 Cr, expecting ~40% EBITDA margins for FY27.